Suppl Figure 1 from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MERJeff Hsu,Colin Chong,Jeffrey Serrill,Levina Goon, Joan Balayan, Eric N. Johnson, Grachelle Lorenzana,Sharon Wu,Kevin G. Leong,Theodore J. Yun,Yong Wang, Faming Jiang,Lynne Bannen,Peter Lamb, Wei Xu,Peiwen Yucrossref（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
